GMP Drink for PKU Study
NCT02915510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2019-10-01
Summary
This study will evaluate the safety, gastrointestinal (GI) tolerance, acceptability and compliance of a Glycomacropeptide-based protein substitute for patients with Phenylketonuria (PKU).
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Glycomacropeptide-based protein substitute
Sponsors & Collaborators
-
Nutricia UK Ltd
lead INDUSTRY
Principal Investigators
-
Rebecca Stratton, PHd · Nutricia Ltd UK
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2019-09-27
- Completion
- 2019-09-27
Countries
- United Kingdom
Study Locations
More Related Trials
-
Testing of Four Home Phenylalanine Monitoring Prototype Devices
NCT02445521 ·Status: COMPLETED
-
Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.
NCT05487378 ·Status: COMPLETED ·Phase: NA
-
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT06971731 ·Status: RECRUITING ·Phase: PHASE3
-
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06628128 ·Status: RECRUITING ·Phase: PHASE3
-
To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria
NCT07318909 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of NGGT002 in PKU Adult Subjects
NCT06061614 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of PKU Sphere
NCT03419819 ·Status: COMPLETED ·Phase: NA
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
NCT03505125 ·Status: COMPLETED
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
NCT03777826 ·Status: COMPLETED ·Phase: NA
-
A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
NCT05827536 ·Status: TERMINATED ·Phase: NA
-
Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)
NCT04085666 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a National Cohort of Adult Patients With Phenylketonuria
NCT01619722 ·Status: COMPLETED
-
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT06629987 ·Status: COMPLETED
-
SNAP: Study Nutrients in Adult PKU
NCT03858101 ·Status: COMPLETED
-
Phenylketonuria and Hyperphenylalaninemia Nutrition Study
NCT01879995 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
NCT06332807 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Nutrition Status of Adults Treated With Pegvaliase
NCT03792451 ·Status: COMPLETED
-
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
NCT05208281 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
NCT00157118 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
NCT06391736 ·Status: RECRUITING ·Phase: PHASE1/PHASE2